Skip to main content

EDITORIAL article

Front. Vet. Sci., 05 January 2024
Sec. Veterinary Experimental and Diagnostic Pathology
Volume 10 - 2023 | https://doi.org/10.3389/fvets.2023.1356032

Editorial: Animal models for basic and applied research in neuroscience

  • 1Department of Cytology and Histology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt
  • 2Animal Sciences Division, Nuclear Institute for Agriculture and Biology College (NIAB-C), Pakistan Institute of Engineering and Applied Sciences (PIEAS), Faisalabad, Pakistan
  • 3Department of Surgery, Anesthesiology and Radiology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt

Animal models play a crucial role in advancing neuroscience research, offering insights into the intricate workings of the brain and nervous system. They provide valuable platforms for studying various neurological conditions, understanding brain functions, and testing potential treatments (1). The objective of this frontier Research Topic is to explore the recent findings that establish connections between abnormalities in nervous system functions and the onset and advancement of both acute and chronic neurodegenerative disorders such as Alzheimer's, Parkinson's, epilepsy, and more. The study of neuroscience relies on animal models to decipher the intricate workings of the human brain and nervous system. Among the various animal subjects used in research, dogs have emerged as valuable models, offering unique insights and contributions to understanding various aspects of neuroscience. Much like humans, dogs can suffer from a variety of neurological conditions, including epilepsy, Alzheimer's disease, and degenerative myelopathy. The study of these naturally occurring conditions in dogs can provide valuable data that has direct relevance to understanding and treating human neurological disorders. In addition, dogs are occasionally used as surgical models to study the effects of spinal cord and brain injuries or to test innovative neurosurgical techniques (2).

In this Research Topic of Frontiers in Veterinary Science/Veterinary Experimental and Diagnostic Pathology, five manuscripts were published: two reviews and three original research articles, whose main contributions and results are briefly presented below.

Epilepsy stands as the most prevalent neurological disorder in dogs, representing a complex brain dysfunction. This condition causes affected dogs to possess a predisposition for experiencing spontaneous epileptic seizures. The origins of epilepsy remain largely unclear, with a limited understanding of its pathogenesis. It is widely believed that a combination of various genes and environmental factors interact, ultimately leading to the manifestation of clinical symptoms (3). In this Research Topic, Rosendahl et al. revealed that dogs affected by idiopathic epilepsy exhibit elevated blood copper levels, an increased copper-to-zinc ratio, and higher selenium levels. Additionally, they demonstrate lower blood chromium levels compared to healthy dogs. These findings emphasize the significance of disturbed trace element levels in dogs diagnosed with idiopathic epilepsy. This study proved that potassium bromide treatment might influence arsenic metabolism in dogs. However, the mechanisms through which trace elements might participate in the development of canine epilepsy or seizures still require further investigation.

In another original research article published by Phochantachinda et al., it was shown that the link between epilepsy and cognitive decline has been studied in canines, revealing a common occurrence of memory impairment among dogs affected by epilepsy. The proteomic profiling they did showed that haptoglobin, ceruloplasmin, α2-macroglobulin, complement factor H, and gelsolin are all connected to epilepsy in dogs and Aβ levels. These proteins potentially serve as diagnostic biomarkers, pending clinical validation, with the potential to be utilized in veterinary practice. Moreover, they are relevant to disease response pathways.

Degenerative myelopathy is a progressive and chronic neurodegenerative spinal cord condition primarily affecting upper motor neurons. Its complexity is mainly linked to a mutation in the SOD1 gene, which plays a toxic role in the disease. Unfortunately, there is currently no specific treatment available for this condition (4). In a clinical trial by Gouveia et al., they evaluated the potential for neural regeneration in dogs with degenerative myelopathy undergoing an intensive neurorehabilitation program along with mesenchymal stem cell transplantation. The hypothesis posits that implementing this combined protocol may offer a promising avenue for a more positive and prolonged progression in these dogs. However, the study's constraints encompassed a limited sample size.

In a review article illustrated the animal sexual behavior from a neuroscience perspective, Tekin et al. showed that hormones secreted from the brain and endocrine glands regulate reproductive activity in domestic mammals. Numerous hormones play essential roles in sustaining reproductive functions.

Neurological degenerative disorders have a significant and increasing healthcare hurdle worldwide. Within the various molecular pathways involved in their development, calpain signaling has been identified as a key contributor to neuronal malfunction and the demise of cells (5). In a review article by Metwally et al., they shed light on the current functions assigned to calpains and offered an overview of the mechanisms that regulate their activity throughout the progression of neurodegenerative disorders. In addition, they discussed how calpain inhibition might be employed as a potential therapy for neuronal dysfunctions in neurodegenerative diseases such as spinal cord injury. The review emphasized an experimental model study of spinal cord injury in adult dogs that demonstrated that inhibiting calpain activity with a specific calpain inhibitor (PD150606) in combination with methylprednisolone sodium succinate resulted in decreased neuronal death, increased the canine Basso, Beattie, and Bresnahan locomotor score, and provided enhanced neuroprotection (6).

In conclusion, animal models are indispensable in neuroscience, serving as a cornerstone for understanding the intricacies of the brain and nervous system. They bridge the gap between basic understanding and practical applications, enabling groundbreaking discoveries and potential treatments for neurological conditions. As technology and ethical considerations progress, these models will continue to shape our knowledge of this vital field of medicine.

Author contributions

EM: Writing – original draft, Writing – review & editing. TH: Writing – original draft, Writing – review & editing. MFA: Writing – original draft, Writing – review & editing.

Funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Mukherjee P, Roy S, Ghosh D, Nandi SK. Role of animal models in biomedical research: a review. Lab Anim Res. (2022) 38:18. doi: 10.1186/s42826-022-00128-1

Crossref Full Text | Google Scholar

2. Löscher W. Dogs as a natural animal model of epilepsy. Front Vet Sci. (2022) 9:928009. doi: 10.3389/fvets.2022.928009

PubMed Abstract | Crossref Full Text | Google Scholar

3. Uriarte A, Maestro Saiz I. Canine versus human epilepsy: are we up to date? J Small Anim Pract. (2016) 57:115–21. doi: 10.1111/jsap.12437

PubMed Abstract | Crossref Full Text | Google Scholar

4. Coates JR, March PA, Oglesbee M, Ruaux CG, Olby NJ, Berghaus RD, et al. Clinical characterization of a familial degenerative myelopathy in Pembroke Welsh Corgi dogs. J Vet Intern Med. (2007) 21:1323–31. doi: 10.1111/j.1939-1676.2007.tb01955.x

PubMed Abstract | Crossref Full Text | Google Scholar

5. Metwally E, Zhao G, Zhang YQ. The calcium-dependent protease calpain in neuronal remodeling and neurodegeneration. Trends Neurosci. (2021) 44:741–52. doi: 10.1016/j.tins.2021.07.003

PubMed Abstract | Crossref Full Text | Google Scholar

6. Metwally E, Al-Abbadi HA, Hashem MA, Mahmoud YK, Ahmed EA, Maaty AI, et al. Selective calpain inhibition improves functional and histopathological outcomes in a canine spinal cord injury model. Int J Mol Sci. (2022) 23:11772. doi: 10.3390/ijms231911772

PubMed Abstract | Crossref Full Text | Google Scholar

Keywords: neuroscience, epilepsy, neurodegenerative (Alzheimer's), animal models and general, Diagnostic Pathology

Citation: Metwally E, Hussain T and Ahmed MF (2024) Editorial: Animal models for basic and applied research in neuroscience. Front. Vet. Sci. 10:1356032. doi: 10.3389/fvets.2023.1356032

Received: 14 December 2023; Accepted: 18 December 2023;
Published: 05 January 2024.

Edited and reviewed by: Francisco Javier Salguero, UK Health Security Agency (UKHSA), United Kingdom

Copyright © 2024 Metwally, Hussain and Ahmed. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Elsayed Metwally, elsayedalalfey@vet.suez.edu.eg; Mahmoud F. Ahmed, mahmoud_ali@vet.suez.edu.eg

Download